The effect of anti-HCV seropositivity on the TNF-alpha level in hemodialysis patients
Sengil, A.Z.; Gürbilek, M.; Altindiş, M.; Uysal, H.; Koşar, A.; Baysal, B.
Clinical Nephrology 44(1): 69-70
1995
ISSN/ISBN: 0301-0430 PMID: 7554537 Document Number: 443184
Document emailed within 1 workday
Related Documents
Caban, M.; Smoleński, O.; Barylak, H.; Kutrzeba, W. 1977: Effect of hemodialysis on the ATP blood level in patients with chronic kidney failure treated with hemodialysis Polski Tygodnik Lekarski 32(35): 1369Kozlov, V.V.; Riabov, S.I.; Dorofeeva, T.B.; von Appen, K.; Spiridonov, V.N. 1984: Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure Terapevticheskii Arkhiv 56(7): 77-81
Gholipour Baradari, A.; Emami Zeydi, A.; Espahbodi, F.; Aarabi, M. 2012: The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: a double blind randomized clinical trial Medicinski Glasnik: Official Publication of the Medical Association of Zenica-Doboj Canton Bosnia and Herzegovina 9(1): 37-41
Malluche, H.H.; Klempa, I.; Hodgson, M.; Feurle, G.; Koch, K.M. 1974: Serum gastrin level and gastric juice secretion in chronic hemodialysis patients and its effect on them by changing ionized serum calcium Verhandlungen der Deutschen Gesellschaft für Innere Medizin 80: 690-692
Aydin, F.; Cubukçu, Kç.; Yetişkul, S.; Yazici, Y.; Kaklikkaya, Nşe. 2002: Retrospective evaluation of HBsAg, anti-HCV, anti-HIV and syphilis reagin antibody seropositivity in blood donors at the Trabzon Farabi Hospital Mikrobiyoloji Bulteni 36(1): 85-90
Prejac, M.; Mikulicic, V.; Jeren-Struić, B.; Kozjak, D. 1980: The effect of hemodialysis and hemofiltration on the serum beta-2 microglobulin content of patients kept on chronic hemodialysis regimen Lijecnicki Vjesnik 102(7-8): 386-391
Satirapoj, B.; Supasyndh, O.; Choovichian, P. 2014: A comparative study of efficacy and safety of the lyophilized powder alpha-erythropoietin and the liquid form alpha-erythropoietin for hemoglobin maintenance in patients with hemodialysis treatment Journal of the Medical Association of Thailand 97(9): 899-906
Kurl, A.; Berry, V.; Dhanoa, J.; Masih, A. 2007: Seropositivity of HBsAg, anti HCV and anti HIV among blood donors: a comparative study on three years of 5 years interval Indian journal of public health 51(1): 41-42
Matsuda, J.; Saitoh, N.; Gotoh, M.; Gohchi, K.; Tsukamoto, M.; Syoji, S.; Miyake, K.; Yamanaka, M. 1995: High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha American Journal of Gastroenterology 90(7): 1138-1141
Rzeszowska, G.; Jagiełło-Wójtowicz, E.; Krawczuk, G.; Baran, E.; Bielec, D.; Fijałka-Rymar, M.; Surmaczyńska, B. 1993: Level of prolactin, gonadotrophin, testosterone, and alpha fetoprotein in serum of blood donors with antibodies to hepatitis c virus (anti-HCV) Przeglad Epidemiologiczny 47(1-2): 21-24
Heinrichs, H.R.; Milde, K.; Junkers, K.; Heinze, V.; Burmeister, P. 1973: Plasma testosterone level of male patients during chronic hemodialysis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 79: 734-738
Shemesh, W.; Iaina, A.; Eliahou, H.E. 1978: Anti-N-like antibody in the serum of patients on chronic hemodialysis Harefuah 94(1): 32-33
Lifshits, N.L.; Ermolenko, V.M.; Tatsievskiĭ, V.A.; Khu, L.Ch. 1979: Changes in aldosterone level and renin activity of blood of patients on programmed hemodialysis Terapevticheskii Arkhiv 51(11): 67-72
Bilgin, N.; Simşek, H.; Haberal, M. 1993: Prevalence of anti-HCV positivity in hemodialysis and renal transplant patients at our center Transplantation Proceedings 25(6): 3261-3262
Galić, G.; Tomić, M.; Galesić, K.; Kvesić, A.; Soljić, M.; Londar, Z.; Valencić, M.; Martinović, Z.; Vuckov, S. 2011: The etiological relation between serum iron level and infection incidence in hemodialysis uremic patients Collegium Antropologicum 35(1): 93-101
Sułowicz, W.; Dolezal, M.; Hejmo, D.; Gerhardt, E.; Ignacak, E. 1992: Occurrence of antibodies against hepatitis C virus (anti-HCV) in patients on long-term hemodialysis Przeglad Lekarski 49(1-2): 67-68
Rossi, E.; Cavatorta, A.; Arisi, L.; Bignardi, L.; David, S.; Garini, G.; Savazzi, G.; Airoldi, G.; Scotti, A.; Cambi, V. 1986: Anti-hypertensive therapy with acebutolol in patients under hemodialysis treatment. 12-month follow-up Minerva Urologica e Nefrologica 38(4): 449-459
Miłoszewska, J.; Janik, P.; Ostrowski, J. 1991: The effect of tumor necrosis factor (TNF-alpha) on calcium (Ca2+) level Archivum Immunologiae et Therapiae Experimentalis 39(1-2): 99-102
Miki, T.; Ohnishi, Y.; Nishizawa, Y.; Morii, H.; Kikunami, K.; Matushita, Y.; Inoue, T.; Inoue, T. 1986: Long-term effect of 1 alpha (OH) D3 on serum osteocalcin level Nihon Jinzo Gakkai Shi 28(3): 295-299
Locht, H.; Pelck, R.; Manthorpe, R. 2008: Diagnostic and prognostic significance of measuring antibodies to alpha-fodrin compared to anti-Ro-52, anti-Ro-60, and anti-La in primary Sjögren's syndrome Journal of Rheumatology 35(5): 845-849